S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CATX Perspective Therapeutics Inc

2.725

-0.005 (-0.18%)

Last Updated: 14:29:43

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Perspective Therapeutics (AMEX:CATX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Perspective Therapeutics Charts.

Perspective Therapeutics (AMEX:CATX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Perspective Therapeutics Charts.

Perspective Therapeutics Inc News

Perspective Therapeutics to Provide Business Highlights and Report Full Year 2024 Financial Results
Friday 21 February 2025 (4 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Perspective Therapeutics to Participate in Upcoming February Investor Conferences
Wednesday 5 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 3 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium
Friday 24 January 2025 (1 month ago) • GlobeNewswire Inc.

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025
Wednesday 22 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Monday 13 January 2025 (1 month ago) • GlobeNewswire Inc.

Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Friday 10 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

More Perspective Therapeutics Inc News Articles

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP PARIBAS ISSUANCE

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions